Results from the phase 3 ENDURE trial (NCT03117816), newly published in Leukemia, demonstrate that ropeginterferon alfa-2b maintenance therapy confers no additional benefit over observation alone ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

Receiving a diagnosis of Chronic Myeloid Leukemia (CML) can be frightening, but it is important to understand that the management of this disease is one of the greatest success stories in modern ...

Lung cancer incidence rates in the United States have undergone a significant transformation over the last several decades, though the trajectory varies notably by gender and ethnicity. While men have ...

SEER based nomograms predicted overall and cancer specific survival in acute erythroid leukemia, with age and chemotherapy ...

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...

Cancer statistics have reached new heights — in good and not-so-good ways. The American Cancer Society (ACS) released its annual report on cancer trends this week, showing for the first time that more ...

Researchers found better detection, treatment and decreased smoking have been immensely helpful in reducing deaths due to cancer.

For the first time ever, the five-year survival rate for all cancers combined has reached 70 percent. While it’s a moment to celebrate, doctors warn the fight is far from over. Sean Stevenson ...

A record 70% of cancer patients are living five years past their diagnosis, according to a report released Tuesday by the American Cancer Society. The annual analysis of cancer statistics says early ...